fig6

Identification of sequence-specific interactions of the CD44-intracellular domain with RUNX2 in the transcription of matrix metalloprotease-9 in human prostate cancer cells

Figure 6. Analysis of the specificity of interaction of RUNX2/CD44-ICD deletion constructs. A: immunoblotting analysis with a RUNX2 antibody (top panel): Nuclear lysates prepared from PC3 cells transfected with indicated constructs were immunoprecipitated with a GFP antibody (lane 1-6) and immunoblotted (IB) with an antibody to RUNX2 (lanes 1-6). An equal amount of nuclear lysate used for immunoprecipitation (IP) was assessed by direct immunoblotting of lysates with an antibody to nucleoporin (Input for IP). A decrease in loading was observed in D2 samples, which corresponded to the possible decrease in the coprecipitation of RUNX2; B: confocal microscopy analyses of cells transfected with CD44-ICD deletion construct and stained with an antibody to GFP (green) and RUNX2 (red). Colocalization is seen in yellow (indicated by arrows in FL, D1, D2, D3, and D4). Scale bar: 25 µm. CD44: Cluster of differentiation 44; ICD: intracellular domain

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/